These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2839961)

  • 21. Effect of brain mast cells degranulation on the corticosterone response to stimulation of central opioid receptors in rats.
    Turoń M; Chłap Z; Gadek-Michalska A; Bugajski J; Połczyńska-Konior G
    Arch Int Pharmacodyn Ther; 1991; 313():151-60. PubMed ID: 1667847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central histaminergic stimulation of hyperlipemic response in rats under stress.
    Bugajski J; Gadek A
    Agents Actions; 1985 Apr; 16(3-4):236-9. PubMed ID: 2861733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosterone response induced by intracerebroventricular administration of met-enkephalin and naloxone in rats under stress.
    Gadek-Michalska A; Cetera B; Bugajski J
    Folia Med Cracov; 1997; 38(3-4):17-26. PubMed ID: 10481378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperlipemic responses induced by centrally administered histamine H1- and H2-receptor agonists in rats.
    Bugajski J; Gadek A
    Agents Actions; 1987 Apr; 20(3-4):255-7. PubMed ID: 2955677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the thalamic submedius nucleus histamine H1 and H 2 and opioid receptors in modulation of formalin-induced orofacial pain in rats.
    Erfanparast A; Tamaddonfard E; Taati M; Dabaghi M
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1089-96. PubMed ID: 26077661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of brain histamine and its receptors in opioid stimulation of the pituitary-adrenocortical activity.
    Bugajski J; Turon M; Tyton J
    Agents Actions Suppl; 1991; 33():77-83. PubMed ID: 2053517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histaminergic stimulation of prolactin secretion mediated via H1- or H2-receptors: dependence on routes of administration.
    Knigge U; Matzen S; Warberg J
    Neuroendocrinology; 1986; 44(1):41-8. PubMed ID: 2878384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal alteration in opiate effects on the hypothalamo-pituitary-adrenal axis: changes in the mechanism of action.
    Kiem DT; Fekete MI; Makara GB
    Eur J Pharmacol; 1995 Jan; 272(2-3):145-50. PubMed ID: 7713158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
    Douglas AJ; Johnstone HA; Wigger A; Landgraf R; Russell JA; Neumann ID
    J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intracerebroventricularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in rats.
    Gadek-Michalska A; Chłap Z; Turoń M; Bugajski J; Fogel WA
    Agents Actions; 1991 Mar; 32(3-4):203-8. PubMed ID: 1862742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of naloxone on central adrenergic stimulation of corticosterone secretion.
    Gadek-Michalska A; Turoń M; Bugajski J
    Folia Med Cracov; 1997; 38(3-4):37-45. PubMed ID: 10481380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-fluoromethylhistidine decreases the Leu-enkephalinamide- and morphine-induced corticosterone response in rats.
    Turon M; Fogel WA; Bugajski J
    Pharmacology; 1991; 42(4):188-96. PubMed ID: 1712972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of histamine receptor sub-types regulating prostacyclin release from human endothelial cells.
    Bull HA; Courtney PF; Rustin MH; Dowd PM
    Br J Pharmacol; 1992 Oct; 107(2):276-81. PubMed ID: 1330171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipolytic responses induced by intracerebroventricular administration of histamine in the rat.
    Bugajski J; Janusz Z
    Agents Actions; 1981 Apr; 11(1-2):147-50. PubMed ID: 6113741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of morphine, naloxone and histamine system on water intake in adult male rats.
    Eidi M; Oryan S; Eidi A; Sepehrara L
    Eur J Pharmacol; 2003 Oct; 478(2-3):105-10. PubMed ID: 14575794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The involvement of central histamine receptors in stress-induced responses of serum corticosterone and free fatty acids and in gastric ulcer development.
    Bugajski J; Gadek A
    Agents Actions; 1981 Apr; 11(1-2):151-5. PubMed ID: 6113742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.